Feb 05, 2021
Post-Pandemic, Many U.S. Frontline Workers Plan To Keep Up Habits That Help Protect From Infection
Jan 15, 2021
Push To Reopen U.S. Schools Puts Nation's Educators At Risk As They Head Back To The Classroom
Dec 17, 2020
Healthcare Savings: Use It, Don't Lose It Before the Dec 31 Deadline (via BlueWillow Biologics)
Dec 04, 2020
At Home and At Work-There is a Lot on the Line for a Frontline Hospital Pharmacist and Mom
Nov 12, 2020
NanoBio® Protect Teams Up with Good360 to Give Back to Frontline Workers and Communities in Need
May 22, 2020
Reducing Risk: NanoBio® Protect Nasal Antiseptic Now Available on Amazon
May 06, 2020
NanoBio® Protect Over-The-Counter Nasal Antiseptic Kills COVID-19 Virus in Lab Tests
Apr 22, 2020
BlueWillow Biologics® Announces Appointment of Chad Costley, MD, MBA, as Chief Medical Officer
Apr 02, 2020
Reducing Risk of Infection: BlueWillow Biologics to Launch NanoBio® Protect OTC Nasal Antiseptic Solution
Oct 23, 2019
BlueWillow Receives FDA Clearance to Begin Phase 1 Study of its Intranasal Anthrax Vaccine
Oct 01, 2019
BlueWillow Awarded NIH Contract to Advance Development of its Therapeutic Peanut Allergy Vaccine
Aug 06, 2019
BlueWillow Biologics Named to Crain's 'Cool Places to Work in Michigan'
Jul 23, 2019
BlueWillow Biologics Awarded Patent for Intranasal Genital Herpes Vaccine
May 29, 2019
BlueWillow Biologics Announces Issuance of Intranasal Anthrax Vaccine Patent
Sep 26, 2018
BlueWillow Biologics Awarded Grant for Chlamydia Vaccine Development
May 30, 2018
BlueWillow Biologics Announces Issuance of Therapeutic Cancer Vaccine Patent
May 07, 2018
NanoBio Announces Corporate Name Change to BlueWillow Biologics and Closes $10M Series A Financing